VRE Detection Medium Using Chromogenic Substrates

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting and identifying vancomycin-resistant Enterococci (VRE) are inadequate as they fail to distinguish between species, leading to challenges in determining appropriate antibiotic therapies and controlling infections, and existing media often result in poor growth and small colonies, making identification difficult and prone to misdiagnosis.

Innovation Solution

A medium containing a nutrient source, selective agents to inhibit non-VRE growth, and Krebs cycle intermediates such as α-ketoglutaric acid to promote growth of VRE, along with chromogenic substrates that produce distinct signals for E. faecalis and E. faecium, enabling rapid and reliable species differentiation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional culture media are used to detect VRE, then the method is simple and allows viable isolation, but the growth is poor and colonies are small taking 48 hours or more to develop

Engineering Contradiction:
Improvegrowth rateVSAvoididentification time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent modifies the chemical composition parameters of the culture medium by incorporating specific nutrients and growth factors that enhance VRE growth rate, reducing identification time from 48+ hours to 24-48 hours while maintaining colony viability and isolability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a simplified detection system that copies key identifying characteristics of VRE species through chromogenic substrates that produce distinct color signals, allowing rapid visual differentiation without requiring complex molecular techniques

Inventive Principle:
Principle #26Copying

2Measurement precision

If substrates are used that substantially all Enterococci species utilize, then detection of Enterococci is achieved, but species differentiation is not possible

Engineering Contradiction:
Improvespecies identification accuracyVSAvoiddetection specificity
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent applies local quality differentiation by incorporating multiple chromogenic substrates that respond differently to specific enzyme profiles of various Enterococci species, allowing each species to produce a distinct local color signal on the medium

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent utilizes color change mechanisms where chromogenic substrates are hydrolyzed by species-specific enzymes to produce distinct colored products, enabling visual differentiation between E. faecalis, E. faecium, and other Enterococci species based on their enzyme profiles

Inventive Principle:
Principle #32Color changes

3Productivity

If sophisticated techniques such as PCR are used, then rapid and sensitive detection is achieved, but the ability to isolate viable organisms for sub-culturing and further analysis is lost

Engineering Contradiction:
Improvedetection speedVSAvoidviable isolation capability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent merges the advantages of rapid detection and viable isolation by creating a culture medium system that simultaneously supports organism growth, enables rapid visual identification through chromogenic substrates, and maintains colony viability for subsequent sub-culturing and analysis

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The medium allows for the rapid growth and reliable identification of VRE species within 24 hours, producing larger colonies and consistent color signals, thereby facilitating accurate clinical intervention and reducing the risk of misidentification.

Implementation Method 1

a Krebs cycle intermediate, most preferably α-ketoglutaric acid and/or salts, derivatives and/or precursors thereof

Methodology Applied
Scientific EffectKrebs cycle:

Implementation Method 2

one or more chromogenic substrates, most preferably two or more chromogenic substrates, which are substrates for species-specific enzymes of vancomycin-resistant Enterococci

Methodology Applied
Scientific EffectEnzyme hydrolysis: Hydrolysis

Implementation Method 3

chromogenic substrates that produce distinct signals for E. faecalis and E. faecium

Methodology Applied
Scientific EffectChromogenic reaction:

Implementation Method 4

an effective amount of one or more selective agents to inhibit the growth of microorganisms other than vancomycin-resistant Enterococci

Methodology Applied
Scientific EffectAntibiotic inhibition:

Implementation Method 5

Enterococci hydrolyze the glycoside, esculin, to form dextrose and esculitin. Esculitin reacts with ferric citrate or other ferrous ions in the medium to form a dark brown or black ring of iron phenolic compounds

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 6

Esculitin reacts with ferric citrate or other ferrous ions in the medium to form a dark brown or black ring of iron phenolic compounds

Methodology Applied
Scientific EffectIron phenolic compound formation:

Data Source

PatentUS9090929B2Medium for detecting and differentiating vancomycin-resistant enterococci
Publication Date: 2015.07.28 OXOID
  • US9090929B2 patent drawing
  • US9090929B2 patent drawing
  • US9090929B2 patent drawing

AI summary

A medium for the growth of vancomycin-resistant Enterococci comprising:—(i) a nutrient medium with an energy source effective to support growth and reproduction of vancomycin-resistant Enterococci; (ii) an effective amount of one or more selective agents to inhibit the growth of microorganisms other than vancomycin-resistant Enterococci; (iii) a Krebs cycle intermediate.